GLOBAL LEADERS IN IGM ANTIBODIES
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Mar 2026)
What this means for you
This application is over — abandoned 16 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97846944
- Mark type
- Stylized text
- Filed
- 20 Mar 2023
- Published for opposition
- 17 Dec 2024
- Abandoned
- 16 Mar 2026
- Attorney of record
- Karen Feisthamel
Goods and services
- Class 036 — Insurance and financial services: Providing financial and investment information in the field of antibodies and antibody research and development
- Class 041 — Education and entertainment services: Education services, namely, arranging and conducting educational congresses in the field of antibodies and antibody research and development
Owner
- IGM Biosciences, Inc., Mountain View, CA, US
- IGM Biosciences, Inc., Mountain View, CA, US
Prosecution history
- 16 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 1 GRANTED
- 18 Feb 2025 — SOU EXTENSION 1 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 21 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 21 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN